KLADGLO Trademark

Trademark Overview


On Friday, February 28, 2025, a trademark application was filed for KLADGLO with the United States Patent and Trademark Office. The USPTO has given the KLADGLO trademark a serial number of 99061876. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Saturday, March 29, 2025. This trademark is owned by Viatris Specialty LLC. The KLADGLO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations to osteoarthritis and rheumatoid arthritis
kladglo

General Information


Serial Number99061876
Word MarkKLADGLO
Filing DateFriday, February 28, 2025
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateSaturday, March 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations to osteoarthritis and rheumatoid arthritis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameViatris Specialty LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMorgantown, WV 26505

Trademark Events


Event DateEvent Description
Friday, February 28, 2025NEW APPLICATION ENTERED
Friday, February 28, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 28, 2025APPLICATION FILING RECEIPT MAILED
Saturday, March 29, 2025ASSIGNED TO EXAMINER